SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-19-019408
Filing Date
2019-04-02
Accepted
2019-04-02 16:58:20
Documents
4
Period of Report
2019-05-02
Effectiveness Date
2019-04-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A a19-6642_1def14a.htm DEF 14A 536729
2 GRAPHIC g66421bci001.jpg GRAPHIC 4938
3 GRAPHIC g66421bci002.jpg GRAPHIC 3128
4 GRAPHIC g66421bgi001.jpg GRAPHIC 6095
  Complete submission text file 0001104659-19-019408.txt   557729
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36856 | Film No.: 19725891
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1